Evia Bio, Inc. funding

Evia Bio, Inc., a biotechnology company based in Minneapolis, MN, filed a Form D with the SEC on September 28, 2026 and reported $5.5M raised.

Amount raised$5.5M

Offering size$5.5M

Filed with the SECSeptember 28, 2026

First saleSeptember 14, 2026

IndustryBiotechnology

SecuritiesEquity

LocationMinneapolis, MN

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far19

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 28

Other health care rounds in Minnesota

AngioInsight, Inc.$16.3M · Nov 10Other Health Care Medical 21, Inc.$550K · Oct 23Biotechnology Pelvital USA, Inc.$520K · Oct 5Other Health Care Allina Health Surgery Center - Brooklyn Park, LLC$135K · Nov 4Other Health Care Surgicare of Minneapolis, Ltd.$0 · Oct 8Other Health Care